Escudier, B <br/><br/>
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.  [electronic resource] 

 -  The Journal of urology  Sep 2002 
 - 959-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/S0022-5347(05)64551-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Kidney Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Prospective Studies